Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
91 - 100 of 155 results
- Vincent Merens (Member)
- Laura Meysman (Member)
- Ellis Michiels (Member)
- Kiavash Movahedi (Member)
- Catharina Muylaert (Member)
- Phuong Anh Nguyen (Member)
- Elissavet Ntemou (Member)
- Christelle Orlando (Member)
- Inge Oudaert (Member)
- Zhaolong Pan (Member)
Projects
91 - 100 of 140
- CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease (OZR EU Bonus).From1 Jan 2019 → 31 Dec 2023Funding: BOF - Other initiatives
- Development of anti-checkpoint strategies using nanobodiesFrom1 Jan 2019 → 31 Dec 2019Funding: FWO research grant KAN
- UPGRADE: Unlocking Precision Gene TherapyFrom1 Jan 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Advanced in vitro models to study liver fibrosisFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- A roadmap to the safe introduction of hESC in the clinic: the case of genetic mosaicism in hESC-derived retinal cellsFrom1 Jan 2019 → 31 Dec 2022Funding: FWO fellowships
- UPGRADE: Unlocking Precision Gene Therapy (OZR EU Bonus)From1 Jan 2019 → 31 Dec 2023Funding: BOF - Other initiatives
- IOF Proof of Concept: Use of PDGFRß as a biomarker of liver fibrosis in blood and urine samplesFrom21 Dec 2018 → 31 Dec 2022Funding: IOF - technology concept exploration
- Modulating epigenetic mechanisms to enhance cancer immunotherapy.From1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
- FWO Hercules MZW: Platform for cell analysis after radioactivity based Molecular Imaging and targeted Therapy of cancer (PeRMIT)From1 May 2018 → 30 Apr 2023Funding: FWO Medium Size Research Infrastructure
- FWO Hercules MZW: ERA platform: Extended RNA Analysis platformFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
Publications
1 - 10 of 1112
- Detection of vertebral fractures in CT using 3D Convolutional Neural Networks(2020)
Authors: Joeri Nicolaes, Steven Raeymaeckers, David Robben, Guido Wilms, Dirk Vandermeulen, Cesar Libanati, Marc DeBois
Pages: 3-14 - T cell-based targeted immunotherapies for patients with multiple myeloma
Authors: Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk Hose, Marc S Raab, Anthony D Ho, et al.
Pages: 1751-1768 - Antigen-mediated regulation in monoclonal gammopathies and myeloma
Authors: Shiny Nair, Joel Sng, Chandra Sekhar Boddupalli, Anja Seckinger, Marta Chesi, Mariateresa Fulciniti, Lin Zhang, Navin Rauniyar, Michael Lopez, Natalia Neparidze, et al.
- High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
Authors: Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, et al.
Pages: 624-627 - Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Authors: Maximilian Merz, Thomas Hielscher, David Schult, Elias K Mai, Marc S Raab, Jens Hillengass, Anja Seckinger, Dirk Hose, Martin Granzow, Anna Jauch, et al.
Pages: 1192-1196 - Sorafenib in patients with refractory or recurrent multiple myeloma
Authors: Anna Yordanova, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Ines Gütgemann, Marc-Steffen Raab, Thomas M Moehler, Hartmut Goldschmidt, Ingo G H Schmidt-Wolf
Pages: 197-200 - The glycome of normal and malignant plasma cells
Authors: Thomas M Moehler, Anja Seckinger, Dirk Hose, Mindaugas Andrulis, Jèrôme Moreaux, Thomas Hielscher, Martina Willhauck-Fleckenstein, Anette Merling, Uta Bertsch, Anna Jauch, et al.
- Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Authors: Chunyan Gu, Carol Holman, Ramakrishna Sompallae, Xuefang Jing, Michael Tomasson, Dirk Hose, Anja Seckinger, Fenghuang Zhan, Guido Tricot, Hartmut Goldschmidt, et al.
- Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
Authors: Niels Weinhold, David C Johnson, Andrew C Rawstron, Asta Försti, Chi Doughty, Jayaram Vijayakrishnan, Peter Broderick, Nasrin B Dahir, Dil B Begum, Fay J Hosking, et al.
Pages: 2513-2517 - A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
Authors: Xiao-Ping Wu, Brian A Walker, Annemiek Broyl, Martin Kaiser, David C Johnson, Rowan Kuiper, Mark van Duin, Walter M Gregory, Faith E Davies, Daniel Brewer, et al.
Pages: 594-601